Home News

DORIA® presentation

The fast onset of action long-acting injectable of risperidone. Based on our ISM® patented technology.

Wed, 25/10/2017 - 13:50 0 min
Download related document
No votes yet
 
Related
2019 Investor Day presentation
0 min
25/11/2019
Financial Results Nine month period 2019 - Video
0 min
25/11/2019
ROVI reports operating revenue growth of 24% and EBITDA growth of 83%
Operating revenue increased by 24% to 270.8 million euros in the first nine months of 2019, mainly driven by the strength of the...
5 min
07/11/2019